Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!" REPLY

被引：0

作者：

Butler, Mark S. ^{[1
,2
]}

Gigante, Valeria ^{[3
]}

Sati, Hatim ^{[3
]}

Paulin, Sarah ^{[3
]}

Al-Sulaiman, Laila ^{[3
]}

Rex, John H. ^{[4
,5
]}

Fernandes, Prabhavathi ^{[6
,7
]}

Arias, Cesar A. ^{[8
,9
]}

Paul, Mical ^{[10
,11
]}

Thwaites, Guy E. ^{[12
,13
]}

Czaplewski, Lloyd ^{[14
]}

Alm, Richard A. ^{[15
]}

Lienhardt, Christian ^{[16
]}

Spigelman, Melvin ^{[17
]}

Silver, Lynn L. ^{[18
]}

Ohmagari, Norio ^{[19
]}

Kozlov, Roman ^{[20
]}

Harbarth, Stephan ^{[21
,22
,23
]}

Beyer, Peter ^{[3
]}

机构：

[1] AMSB Chem Consulting, Brisbane, Qld, Australia

[2] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia

[3] WHO, Antimicrobial Resistance Div, Geneva, Switzerland

[4] F2G Ltd, Eccles, Cheshire, England

[5] Univ Texas Hlth Sci Ctr, EMcGovern Med Sch, Houston, TX USA

[6] GARDP, Scient Advisory Comm, Geneva, Switzerland

[7] Natl Biodefense Sci Board, Hlth & Human Serv, Washington, DC USA

[8] Houston Methodist Res Inst, Ctr Infect Dis Res, Houston, TX USA

[9] UTHealth Sch Publ Hlth, Ctr Infect Dis, Houston, TX USA

[10] Infect Dis Inst, Rambam Hlth Care Campus, Haifa, Israel

[11] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel

[12] Univ Oxford, Clin Res Unitgrid 412433 3, Ho Chi Minh City, Vietnam

[13] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England

[14] Chem Biol Ventures Ltd, Abingdon, Oxon, England

[15] Boston Univ, OCARB X, Boston, MA USA

[16] Univ Montpellier, Inst Rech Dev, INSERM, Montpellier, France

[17] TB Alliance, New York, NY USA

[18] LL Silver Consulting, Springfield, NJ USA

[19] Natl Ctr Global Hlth & Med, Shinjuku City, Tokyo, Japan

[20] Smolensk State Med Univ, TInstitute Antimicrobial Chemotherapy, Smolensk, Russia

[21] Natl Ctr Infect Prevent, Bern, Switzerland

[22] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland

[23] WHO Collaborating Ctr Patient Safety, Fac Med, Geneva, Switzerland

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2022年 / 66卷 / 04期

关键词：

D O I：

10.1128/aac.00223-22

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页数：2

共 50 条

[41] Genetic relatedness of third-generation cephalosporin-resistant Escherichia coli among livestock, farmers, and patients in Japan
Nakano, Ryuichi
Nakano, Akiyo
Nishisouzu, Ryuji
Hikosaka, Kenji
Suzuki, Yuki
Kamoshida, Go
Tansho-Nagakawa, Shigeru
Endo, Shiro
Kasahara, Kei
Ono, Yasuo
Yano, Hisakazu
ONE HEALTH, 2023, 16
[42] GENETIC RELATEDNESS OF THIRD-GENERATION CEPHALOSPORIN-RESISTANT ESCHERICHIA COLI AMONG LIVESTOCK, FARMERS, AND PATIENTS IN JAPAN
Nakano, Ryuichi
Nakano, Akiyo
Nishisouzu, Ryuji
Hikosaka, Kenji
Suzuki, Yuki
Kamoshida, Go
Shigeru, Tansho-Nagakawa
Kasahara, Kei
Ono, Yasuo
Yano, Hisakazu
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 31 : S25 - S26
[43] Third-Generation Cephalosporin-Resistant Non-Typhoidal Salmonella Isolated from Human Feces in Japan
Saito, Satomi
Koori, Yoshio
Ohsakil, Yusuke
Osaka, Shunsuke
Oana, Kozue
Nagano, Yukiko
Arakawa, Yoshichika
Nagano, Noriyuki
JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2017, 70 (03) : 301 - 304
[44] Epidemiology of third-generation cephalosporin-resistant community-acquired Enterobacteria isolated from elderly patients
Thibaut, S.
Caillon, J.
Marquet, A.
Grandjean, G.
Potel, G.
Ballereau, F.
MEDECINE ET MALADIES INFECTIEUSES, 2014, 44 (02): : 57 - 62
[45] Variability of intestinal colonization with third-generation cephalosporin-resistant Enterobacteriaceae and antibiotic use in intensive care units
Thiebaut, Anne C. M.
Arlet, Guillaume
Andremont, Antoine
Papy, Emmanuelle
Sollet, Jean-Pierre
Bernede-Bauduin, Claire
Guillemot, Didier
Schlemmer, Benoit
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (06) : 1525 - 1536
[46] Third-Generation Cephalosporin Resistance in Intrinsic Colistin-Resistant Enterobacterales Isolated from Retail Meat
Odoi, Justice Opare
Takayanagi, Sayo
Yossapol, Montira
Sugiyama, Michiyo
Asai, Tetsuo
ANTIBIOTICS-BASEL, 2021, 10 (12):
[47] High admission prevalence of fluoroquinolone resistance in third-generation cephalosporin-resistant Enterobacteriaceae in German university hospitals
Rohde, Anna M.
Wiese-Posselt, Miriam
Zweigner, Janine
Schwab, Frank
Mischnik, Alexander
Seifert, Harald
Gastmeier, Petra
Kern, Winfried V.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (06) : 1688 - 1691
[48] Characteristics of third-generation cephalosporin-resistant Salmonella from retail chicken meat produced by integrated broiler operations
Jeon, Hye Young
Seo, Kwang Won
Kim, Yeong Bin
Kim, Dong Kyu
Kim, Shin Woo
Lee, Young Ju
POULTRY SCIENCE, 2019, 98 (04) : 1766 - 1774
[49] In Vitro Activity and Clinical Efficacy of Faropenem against Third-Generation Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae
Ishikawa, Kazuhiro
Uehara, Yuki
Mori, Nobuyoshi
Mikami, Yumiko
Tokioka, Sayuri
Kobayashi, Daiki
Goke, Hisa
Inukai, Tatsuya
Sakurai, Aki
Doi, Yohei
Kawakami, Sayoko
Kayama, Shizuo
Sugai, Motoyuki
Nakamura, Shigeki
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)
[50] Genomic epidemiology of third-generation cephalosporin-resistant Escherichia coli from companion animals and human infections in Europe
Biguenet, Adrien
Valot, Benoit
El Garch, Farid
Bertrand, Xavier
Hocquet, Didier
ONE HEALTH, 2025, 20

← 1 2 3 4 5 →